Lisata Therapeutics
LSTA
LSTA
34 hedge funds and large institutions have $5M invested in Lisata Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.07% more ownership
Funds ownership: 0.97% → 1.04% (+0.07%)
18% less capital invested
Capital invested by funds: $6.13M → $5M (-$1.13M)
Holders
34
Holding in Top 10
–
Calls
$172K
Puts
$11K
Top Buyers
| 1 | +$399K | |
| 2 | +$73K | |
| 3 | +$61.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$13K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$10K |
Top Sellers
| 1 | -$79.1K | |
| 2 | -$68K | |
| 3 | -$36K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.3K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$14.6K |